Enveric Biosciences, Inc. (ENVB)
$1.47+1.38%Close
SELLRECOVERY · day 28
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $877,608
- Beta
- 1.11
- P/E (TTM)
- -0.09
- Short % float
- 2.83%
- Days to cover
- 1.0
- SI change
- -32.5%
- 1W
- -2.65%
- 1M
- +3.52%
- vs SPY 1W
- -3.07%
- vs SPY 1M
- +1.46%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ENVB?
- LOPJLB’s latest quantitative signal on Enveric Biosciences, Inc. (ENVB) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is ENVB in?
- Enveric Biosciences, Inc. (ENVB) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Enveric Biosciences, Inc. (ENVB) do?
- Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alo…